APA (7th ed.) Citation

Tadolini, M., Lingtsang, R. D., Tiberi, S., Enwerem, M., D'Ambrosio, L., Sadutshang, T. D., . . . Migliori, G. B. (2016). Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine. The European respiratory journal, 48(5), 1527-1529. https://doi.org/10.1183/13993003.01552-2016

Chicago Style (17th ed.) Citation

Tadolini, Marina, Rangjung Dolma Lingtsang, Simon Tiberi, Martin Enwerem, Lia D'Ambrosio, Tsetan Dorji Sadutshang, Rosella Centis, and Giovanni Battista Migliori. "Cardiac Safety of Extensively Drug-resistant Tuberculosis Regimens Including Bedaquiline, Delamanid and Clofazimine." The European Respiratory Journal 48, no. 5 (2016): 1527-1529. https://doi.org/10.1183/13993003.01552-2016.

MLA (9th ed.) Citation

Tadolini, Marina, et al. "Cardiac Safety of Extensively Drug-resistant Tuberculosis Regimens Including Bedaquiline, Delamanid and Clofazimine." The European Respiratory Journal, vol. 48, no. 5, 2016, pp. 1527-1529, https://doi.org/10.1183/13993003.01552-2016.